| Document Date: 2015-03-24 06:46:08
Open Document File Size: 227,37 KBShare Result on Facebook
Company National Radiotherapy Advisory Group / / Country Switzerland / United Kingdom / / IndustryTerm metal / skull base site / high-energy proton treatment / Low energy / metal stabilisation / high-energy proton beams / imaging / energy / / MedicalCondition cancers / minimal residual disease / cancer / disease / rare cancers / Chondrosarcoma / adult cancer / different rare cancers / metastasis / assessment The tumours / bone tumours / TYA cancers / Soft Tissue Sarcoma / Soft tissue sarcomas / tumour / Adenoid Cystic Carcinoma / Esthesioneuroblastoma / skeletal system cancers / metastatic disease / second malignancy / appropriate adult cancer / skull base tumours / Primary bone sarcoma / selected cancers / Adult cancers / Chordoma / Squamous cell cancer / different cancer / sacral tumours / second cancers / commoner cancers / tumours / Adenocarcinoma / / MedicalTreatment proton beam therapy / chemotherapy / Radiotherapy / surgery / radiation / adjuvant therapy / / Organization World Health Organization / UK PBT National Service / American Society for Therapeutic Radiology and Oncology / NHS / / Position RT / / Technology radiation / chemotherapy / /
SocialTag |
Clinical Commissioning Policy: Proton Beam Radiotherapy (High Energy) for Skull Base Tumour Treatment – NHS Overseas Programme (Adult) Reference: NHS England xxx/x/x 1